Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
Ju J, Li J, Lin Q, Xu H
Published in Phytomedicine
Methodology
Cochrane-handbook-based systematic review and meta-analysis of 16 randomised clinical trials (2147 participants) of berberine for dyslipidaemia, assessing lipid parameters and adverse events
Key Findings
Berberine improved lipid parameters versus control, but the included trials were largely of low methodological quality.
Conclusions
Lipid benefits are plausible while the certainty of evidence is limited.
Limitations
High or unclear risk of bias in most trials; regional concentration of studies; heterogeneity.
Supplements Studied
Sixteen trials with total of 2147 participants were judged to be eligible and were included in the meta-analysis.
Study Details
Access Study
Disclosures
Funding
Not reported
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.